Pediatrix Medical MD
NYSE MD
$27.04 +0.16 (+0.60%)
At close: Sep 4, 2026 · 4:00 PM EDT

Pediatrix Medical (MD) Asset Writedowns and Impairment (2023 - 2024)

Pediatrix Medical's (MD) quarterly Asset Writedowns and Impairment came in at -$3.6 million in Q4 2024, down 102.14% year-over-year from $168.3 million in Q1 2024, and down 117.89% quarter-over-quarter from $20.1 million in Q2 2024.

Analysis

Pediatrix Medical (MD) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

Pediatrix Medical (MD) has reported Asset Writedowns and Impairment for 2 consecutive years, with -$3.6 million the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment fell 102.14% year-over-year to -$3.6 million in Q4 2024; TTM through Dec 2025 was -$3.6 million, a 101.95% decrease from a year earlier, with the FY2024 full-year figure at $178.4 million, up 6.01% from the prior year.
  • Asset Writedowns and Impairment was -$3.6 million for Q4 2024 at Pediatrix Medical, down from $20.1 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $168.3 million in Q4 2023 and troughed at -$3.6 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.76 Bn 12.64 Bn 1.16 Bn
2 RadNet 5.80 Bn 5.37 Bn 88.08 Mn
3 Concentra Group Holdings Parent 4.40 Bn 4.26 Bn 192.10 Mn
4 Privia Health 2.61 Bn 2.25 Bn -
5 Pediatrix Medical 2.20 Bn 1.79 Bn -
6 Fresenius Medical Care AG 2.11 Bn 1.41 Bn 1.52 Bn
7 Progyny 2.01 Bn 1.77 Bn 89.30 Mn
8 Surgery Partners 1.87 Bn 3.08 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.47 Bn 41.94 Mn
10 Starling Oncology 595.78 Mn 554.69 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.60 Mn
Jun 30, 2024 20.11 Mn
Dec 31, 2023 168.31 Mn